Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Hot Flashes 3Breast Neoplasms 3Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Sleep Wake Disorders 1Depression 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Adenocarcinoma 1

Interventions

Therapeutics 21Psychiatric Rehabilitation 20Surveys and Questionnaires 7Early Intervention, Educational 6Counseling 6Yoga 5Psychosocial Intervention 5Cognitive Behavioral Therapy 5Behavior Therapy 5Mindfulness 4Ketamine 4Exercise 4Escitalopram 4Acupuncture Therapy 4Saline Solution 3Psilocybin 3Mindfulness-Based Stress Reduction 3Mindfulness-Based Cognitive Therapy 3Methods 3Exercise Therapy 3Control Groups 3Citalopram 3Chemotherapy, Adjuvant 3Sugars 2Sertraline 2Palliative Care 2Observation 2Niacin 2Mental Status and Dementia Tests 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Depression × Venlafaxine Hydrochloride × Clear all
NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡